OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Late-Onset Psoriatic Arthritis: Are There Any Distinct Characteristics? A Retrospective Cohort Data Analysis
Chrysoula G. Gialouri, Gerasimos Evangelatos, Alexios Iliopoulos, et al.
Life (2023) Vol. 13, Iss. 3, pp. 792-792
Open Access | Times Cited: 6
Chrysoula G. Gialouri, Gerasimos Evangelatos, Alexios Iliopoulos, et al.
Life (2023) Vol. 13, Iss. 3, pp. 792-792
Open Access | Times Cited: 6
Showing 6 citing articles:
Increase in comorbidities with age among patients with psoriatic arthritis: a multicenter observational study
S Chandrashekara, Padmanabha Shenoy, Uma Kumar, et al.
Rheumatology International (2025) Vol. 45, Iss. 1
Closed Access
S Chandrashekara, Padmanabha Shenoy, Uma Kumar, et al.
Rheumatology International (2025) Vol. 45, Iss. 1
Closed Access
Niosomal Curcumin Suppresses IL17/IL23 Immunopathogenic Axis in Skin Lesions of Psoriatic Patients: A Pilot Randomized Controlled Trial
Hanieh Kolahdooz, Vahid Khori, Vahid Erfani‐Moghadam, et al.
Life (2023) Vol. 13, Iss. 5, pp. 1076-1076
Open Access | Times Cited: 5
Hanieh Kolahdooz, Vahid Khori, Vahid Erfani‐Moghadam, et al.
Life (2023) Vol. 13, Iss. 5, pp. 1076-1076
Open Access | Times Cited: 5
Psoriasis vulgaris patient with psoriatic arthritis managed with interleukin-17A inhibitor: Balancing benefits and adverse effects
Wina S. Utama, Wahyu Lestari, Sitti Hajar, et al.
Narra J (2024) Vol. 4, Iss. 1, pp. e207-e207
Open Access | Times Cited: 1
Wina S. Utama, Wahyu Lestari, Sitti Hajar, et al.
Narra J (2024) Vol. 4, Iss. 1, pp. e207-e207
Open Access | Times Cited: 1
Real-World Drug Survival of Biologics and Targeted Synthetic Disease-Modifying Anti-rheumatic Drugs Among Patients with Psoriatic Arthritis
Vered Rosenberg, Howard Amital, Gabriel Chodick, et al.
Drugs & Aging (2024) Vol. 41, Iss. 8, pp. 685-697
Open Access | Times Cited: 1
Vered Rosenberg, Howard Amital, Gabriel Chodick, et al.
Drugs & Aging (2024) Vol. 41, Iss. 8, pp. 685-697
Open Access | Times Cited: 1
Molecular Background and Clinical Implications of Glucose Disorders in Patients with Psoriatic Arthritis
Bogna Grygiel‐Górniak, Weronika Skoczek
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5814-5814
Open Access | Times Cited: 2
Bogna Grygiel‐Górniak, Weronika Skoczek
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 5814-5814
Open Access | Times Cited: 2
Weil’s disease with multiple organ dysfunction, community-acquired pneumonia and septic shock: The role of rapid diagnosis and management
Berty Denny Hermawati, Brigitta Devi Anindita Hapsari, Evi Liliek Wulandari, et al.
Narra J (2024) Vol. 4, Iss. 1, pp. e587-e587
Open Access
Berty Denny Hermawati, Brigitta Devi Anindita Hapsari, Evi Liliek Wulandari, et al.
Narra J (2024) Vol. 4, Iss. 1, pp. e587-e587
Open Access
